Summary & Overview
HCPCS L8682: Implantable Neurostimulator Radiofrequency Receiver
HCPCS Level II code L8682 designates an implantable neurostimulator radiofrequency receiver, a hardware component of implantable neurostimulation systems used to receive radiofrequency signals for powering or controlling implanted stimulators. Nationally, this device-level code matters for durable medical equipment and implantable device billing, inventory management, and device-specific reimbursement pathways that affect hospitals, ambulatory surgery centers, and durable medical equipment suppliers.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical role and typical sites of service, followed by national benchmarking context where available. The publication outlines common modifiers associated with device billing, notes where input data are missing, and highlights related administrative considerations such as supply versus device classification and billing lines for implantable components.
This summary prepares clinicians, billing professionals, and policy analysts to interpret how L8682 is used in claims and claim lines, what to expect in payer coverage conversations, and which operational areas — procurement, coding, and facility billing — are most impacted by implantable neurostimulator receiver devices.
Billing Code Overview
HCPCS Level II code L8682 describes an implantable neurostimulator radiofrequency receiver. This device is used as a component of implantable neurostimulation systems that receive radiofrequency signals to power or control implanted neurostimulators.
Service type: Implantable neurostimulation device component
Typical site of service: Inpatient or outpatient surgical settings where implantable neurostimulation systems are placed or managed, including ambulatory surgery centers and hospital operating rooms
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient with refractory chronic neuropathic pain following failed conservative therapy is evaluated for implantation of an implantable neurostimulator radiofrequency receiver. The typical workflow begins with a multidisciplinary assessment by a pain medicine specialist and neurosurgeon, confirming indications such as chronic axial low back pain, failed back surgery syndrome, or complex regional pain syndrome. A trial of peripheral or spinal cord stimulation may precede permanent implantation. On the day of implantation, the patient presents to an operating room or ambulatory surgery center; typical site of service is the operating room in a hospital or a hospital-affiliated outpatient surgical center. Under monitored anesthesia care or general anesthesia, the lead(s) are placed percutaneously or via a small open approach, connected to the implanted radiofrequency receiver (L8682), and the neurostimulator is tested intraoperatively. Postoperative programming and device interrogation occur in the device clinic, with follow-up visits for wound check, pain control assessment, and formal device programming. Imaging (fluoroscopy or radiography) is used intraoperatively and for postoperative confirmation of device position. Billing for the implanted radiofrequency receiver is submitted using HCPCS Level II code L8682 with applicable procedure and evaluation codes for implantation, device programming, and follow-up care.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|